Abstract: A therapeutic food composition for treatment of diabetic patients to diminish fluctuations in blood sugar levels and prevent hypoglycemic episodes, comprising per unit about 20-50 grams of nutrients including slowly absorbed or digested complex carbohydrate, preferably uncooked cornstarch; more rapidly absorbed complex carbohydrate; protein; fat; and at least one sweetening agent, but less than about 3 grams of any simple sugar other than fructose. Fructose may be present in the composition in quantities greater than 3 grams per unit. Diabetic patients may be treated to diminish blood sugar fluctuations and prevent hypoglycemia via the administration of the novel food composition as an evening or pre-bedtime snack or during the daytime hours to patients receiving insulin therapy or engaging in activities that might provoke hypoglycemia.

Abstract: The invention relates to a method of detection, a sensor and a test-kit which find application in immunological detection (e.g., immunoassay). The invention provides, inter alia, a method of detection, suitable for use in immunological detection of an entity, which method includes the use of a secondary species (as defined in the specification), the use of a first detectable species, and the use of a second detectable species. The method may include, for example, the use of a primary species, a secondary species, a first detectable species and a second detectable species. The primary species may be, for example, an antibody or a ligand. The secondary species may be, for example, an auxiliary species such as an auxiliary binder or an auxiliary ligand, or a species which has a part which is an auxiliary function. The entity to be detected may be an analyte species as such or may be an entity which carries or includes analytes species.

Abstract: A process is provided for producing a purified extract from Ginkgo biloba leaves by solvent extraction with selected solvents. In the process, a crude or partially purified extract is subjected to solvent extraction with a solvent comprising toluene and n-butanol. Pharmaceutical compositions comprising dimeric flavones and/or polyphenols are also described.

Abstract: A method of treating a patient suffering from antigen-induced asthma who has been challenged with an antigen, or providing chronic treatment to an asthma patient to reduce airway hyperresponsiveness, comprising intrabronchial administration to the patient of a pharmaceutical composition containing in each dose about 0.05 to about 1.0 mg of ultra-low molecular weight heparins (ULMWH), having an average molecular weight of 3,000 daltons or less, per kilogram of patient body weight, Inhalant pharmaceutical compositions for use in the novel treatment method are also provided.

Abstract: An improved highly alkaline hair straightening emulsion and a two component system for preparing the emulsion are provided. The emulsion employs a combination of strong nitrogenous organic base and alkali metal hydroxide in the presence of an alkaline earth metal cation. Neither the amount of the alkali metal hydroxide nor the amount of organic base present in the emulsion is sufficient by itself to effectively permanently straighten naturally curly hair. Alkaline earth metal hydroxides are characteristically ineffective as permanent hair straighteners. However, surprisingly, the combination is effective for achieving permanent straightening of hair within a treatment time of not more than about 30 minutes. In use, the emulsion also substantially avoids scalp skin irritation. Also, hair discoloration and hair breakage are minimized.

Abstract: A biological product comprises a milk ingredient and bacteria including bacterium ferments, bolgarium bacillus, acedofilium bacillius, lactobacterium gelveticum, termofilium streptococum, bacterium kazey.

Abstract: A process is provided for producing a purified extract from Ginkgo biloba leaves by solvent extraction with selected solvents. In the process, a crude or partially purified extract is subjected to solvent extraction with a solvent comprising toluene and n-butanol. Pharmaceutical. compositions comprising dimeric flavones and/or polyphenols are also described.

Abstract: A therapeutic food composition for treatment of diabetic patients to diminish fluctuations in blood sugar levels and prevent hypoglycemic episodes, comprising per unit about 20-50 grams of nutrients including a slowly absorbed or digested complex carbohydrate, preferably cornstarch; a more rapidly absorbed complex carbohydrate; protein; and fat, but substantially no simple sugars. Diabetic patients may be treated to diminish blood sugar fluctuations and prevent hypoglycemia via the administration of the novel food composition as an evening or pre-bedtime snack or during the daytime hours to patients receiving insulin therapy or engaging in activities that might provoke hypoglycemia.

Abstract: An echo canceller (1) for full duplex digital data transmission in a transmitter/receiver unit when connected via a hybrid circuit (2) to one end of a two wire line (3). In order to provide adequate cancellation at a line data rate of 160 kbit/s over 7-8 km, a data bit history of at least 9 bits is used to address a memory having at least 3 partitions (41-44) with the first partition (41) being addressed by a sequence of at least 3 data bits. This partitioning achieves a small memory size, less than 2 kbits, and a small total chip area for integrated circuit realization of the canceller together with a clocking speed for moderate power consumption is maintained by using serial arithmetic (61-63) for adding the partition outputs together with pipelining (D1, D21-D24). An exponentially quantitizing analog-to-digital converter error signal circuit (9), shown in detail in FIG. 2, is used which has wider application to echo cancellers other than the partitioned memory compensation type.